FINWIRES · TerminalLIVE
FINWIRES

Changchun High-Tech Industry Gets China Nod for GenSci155 Trial

By

Changchun High-Tech Industry (SHE:000661) subsidiary GeneScience obtained China's regulatory approval to conduct clinical trials for GenSci155 injection.

The drug is indicated for preventing bronchopulmonary dysplasia in premature infants and treating acute ischemic stroke, according to a Thursday filing with the Shenzhen bourse.

Shares of the drug manufacturer closed 2% lower Thursday.

Related Articles

Asia

Shanghai International Port Expects Rise in Container Throughput, Decline in Cargo in May

Shanghai International Port (SHA:600018) expects its container throughput in May to have risen 3% year on year to 4.8 million TEUs, or twenty-foot equivalent units, according to a Shanghai bourse filing on Thursday.Cargo throughput for the same month is also expected to have declined 2.1% to 513 million tons from a year earlier.The Chinese port operator's shares slipped 1% at the close.

$SHA:600018
Asia

Dongkuk Structures Secures Wind Turbines Supply Agreement from Vestas

Dongkuk Structures & Construction (KOSDAQ:100130) secured a wind turbine supply order from Vestas Manufacturing, according to a Thursday filing with the Korea Exchange.The contract, valued at 31.6 billion won, is valid till Aug. 5, 2027.Shares of Dongkuk Structures & Construction jumped nearly 9% at market close.

$KOSDAQ:100130
Asia

Market Chatter: Weakening Rupiah Not Due to Indonesian Govt Fiscal Policies, Finance Minister Says

The weakening of the Indonesian currency toward 18,000 rupiah per U.S. dollar does not reflect worsening government finances, The Jakarta Globe reported Thursday, citing Finance Minister Purbaya Yudhi Sadewa.Purbaya dismissed concerns that the government's recent fiscal policies were reckless while speaking to reporters.He supported his claim with state budget figures, stating that the budget deficit dropped to roughly 0.7% of GDP and tax revenue increased over 22% from a year prior, the newswire reported.The deterioration of the rupiah has instead been a result of market sentiment and speculation, Purbaya reportedly said.He also pushed back on rumored instructions to banks to carry out stress tests if the currency goes below the 18,000 rupiah per U.S. dollar mark, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^JKSE